TMS in combination with a pain directed intervention for the treatment of fibromyalgia - A randomized, double-blind, sham-controlled trial.

BACKGROUND: Fibromyalgia Syndrome (FMS) is a highly prevalent condition, that causes chronic pain and severe reduction in quality of life and productivity, as well as social isolation. Despite the significant morbidity and economic burden of FMS, current treatments are scarce. OBJECTIVE: To investigate whether stimulation of ACC -mPFC activity by dTMS enhances a pain-directed psychotherapeutic intervention. METHODS: 19 FMS patients were randomised to receive either 20 sessions of dTMS or sham stimulation, each followed by a pain-directed psychotherapeutic intervention. With the H7 HAC coil or sham stimulation, we targeted the ACC -mPFC; specific brain areas that play a central role in pain processing. Clinical response to treatment was assessed with the McGill Pain Questionnaire Short Form (SF-MPQ), the Visual Analogue Fibromyalgia Impact Questionnaire, the Brief Pain Inventory questionnaire, and the Hamilton Depression Rating Scale. RESULTS: DTMS treatment was safe and well tolerated by FMS patients. A significant decrease in the combined sensory and affective pain dimensions was specifically demonstrated in the dTMS cohort, as measured by the SF-MPQ (Significant group × time interaction [F(2, 32) = 3.51, p < .05,ηp2 = 0.18]; No significant changes were found in depressive symptoms in both the dTMS and sham groups. CONCLUSION: Our results suggest that a course of dTMS combined with a pain-directed psychotherapeutic intervention can alleviate pain symptoms in FMS patients. Beyond clinical possibilities, future studies are needed to substantiate the innovative hypothesis that it is not dTMS alone, but rather dTMS-induced plasticity of pain-related networks, that enables the efficacy of pain-directed psychotherapeutic interventions.

The utility of the Poreh Nonverbal Memory Test (PNMT) for the detection of noncredible performance.

Performance validity tests (PVTs) aim to detect noncredible performance during neuropsychological testing. Despite their established utility, their cognitively undemanding nature and format may unintentionally reveal their purpose, leading to ongoing efforts to develop novel PVTs. In this study, we examined the ability of the embedded validity indices of the Poreh Nonverbal Memory Test (PNMT) to detect simulation. An initial sample of 61 participants was randomly assigned to either a simulation or control condition. Participants then completed the PNMT, the Test of Memory Malingering (TOMM), and the Digit Span subtest. A second validation study using 49 participants was conducted in Israel utilizing the same paradigm. In both studies, simulators were less accurate, exhibited shallow and- at times- reversed PNMT learning curves, and obtained lower scores on the delayed and recognition trials. Additionally, PNMT indices showed similar sensitivity and specificity and were highly correlated with more established validity measures. These findings, however, should be considered preliminary and await further validation in clinical settings.

Stress and Right Prefrontal Transcranial Direct Current Stimulation (tDCS) Interactive Effects on Visual Working Memory and Learning.

Stress impacts prefrontal cortex (PFC) activity and modulates working memory performance. In a recent study, stimulating the dorsolateral PFC (dlPFC) using transcranial direct current stimulation (tDCS) interacted with social stress in modulating participants' working memory. More specifically, stress disrupted the enhancing effects of dlPFC tDCS on working memory performance. The current study aimed to further explore these initial findings by randomizing healthy females to four experimental conditions (N = 130); stimulation (right dlPFC tDCS vs. sham) and stress manipulation (social stress vs. control). Participants performed cognitive tasks (i.e., visual working memory task and a visual declarative memory task) at baseline and post-stimulation. They also completed self-report measures of stress and anxiety. A significant stimulation × stress interaction was evident in the declarative memory (One-Card Learning, OCL) task, while working memory performance was unaffected. Though tDCS stimulation and stress did not interact to affect working memory, further research is warranted as these initial findings suggest that immediate visual-memory learning may be affected by these factors. The limited number of earlier studies, as well as the variability in their designs, provides additional impetus for studying the interactive effects of stress and tDCS on human visual learning.

[MULTI-DIMENSIONAL APPROACH FOR ASSESSING CREDIBILITY OF INDIVIDUALS CLAIMING COMBAT PTSD COMPENSATIONS: A PRELIMINARY STUDY].

INTRODUCTION: Diagnosis of combat post-traumatic stress disorder (PTSD) is largely based on the subjective reports of the claimant and is therefore prone to over-diagnosis of symptoms. Over-diagnosis of combat PTSD is associated with harm. Therefore, it is important to assess the claimant's credibility in assessing PTSD as accurately as possible.

Effects of diagnosis threat on cognitive complaints after COVID-19.

OBJECTIVE: The term "long-COVID" refers to the persistence of neurological symptoms after being ill with COVID-19 (e.g., headaches, fatigue, and attentional impairment). Providing information about long-COVID (i.e., "diagnosis threat") increased subjective cognitive complaints among recovered COVID-19 patients compared with those exposed to neutral information (Winter & Braw, 2022). Notably, this effect was particularly prominent among more suggestible participants. Our aim in the current study was to validate these initial findings and to explore the impact of additional variables (e.g., suggestibility). METHOD: Recovered patients (n = 270) and controls (n = 290) reported daily cognitive failures after being randomly assigned to either a diagnosis threat (exposure to an article providing information regarding long-COVID) or a control condition. RESULTS: Recovered patients, but not controls, reported more cognitive failures in the diagnosis threat condition compared with the control condition. Diagnosis threat added significantly to the prediction of cognitive complaints based on relevant demographic variables and suggestibility. Diagnosis threat and suggestibility interacted (i.e., suggestible individuals were particularly vulnerable to the impact of a diagnosis threat). CONCLUSIONS: Diagnosis threat may contribute to the persistence of complaints regarding cognitive impairment among recovered COVID-19 patients. Suggestibility may be an underlying mechanism that increases the impact of diagnosis threat. Other factors, such as vaccination status, may be at play though we are only at the initial stages of research concerning their impact. These may be the focus of future research, aiding in identifying risk factors for experiencing COVID-19 symptoms past the resolution of its acute phase. (PsycInfo Database Record (c) 2023 APA, all rights reserved).

Adaptation and initial validation of the Arabic version of the Word Memory Test (WMTARB).

BACKGROUND: The feigning of cognitive impairment is common in neuropsychological assessments, especially in a medicolegal setting. The Word Memory Test (WMT) is a forced-choice recognition memory performance validity test (PVT) which is widely used to detect noncredible performance. Though translated to several languages, this was not done for one of the most common languages, Arabic. The aim of the current study was to evaluate the convergent validity of the Arabic adaptation of the WMT (WMTARB) among Israeli Arabic speakers. METHODS: We adapted the WMT to Arabic using the back-translation method and in accordance with relevant guidelines. We then randomly assigned healthy Arabic speaking adults (N = 63) to either a simulation or honest control condition. The participants then performed neuropsychological tests which included the WMTARB and the Test of Memory Malingering (TOMM), a well-validated nonverbal PVT. RESULTS: The WMTARB had high split-half reliability and its measures were significantly correlated with that of the TOMM (p < .001). High concordance was found in classification of participants using the WMTARB and TOMM (specificity = 94.29% and sensitivity = 100% using the conventional TOMM trial 2 cutoff as gold standard). As expected, simulators' accuracy on the WMTARB was significantly lower than that of honest controls. None of the demographic variables significantly correlated with WMTARB measures. CONCLUSION: The WMTARB shows initial evidence of reliability and validity, emphasizing its potential use in the large population of Arabic speakers and universality in detecting noncredible performance. The findings, however, are preliminary and mandate validation in clinical settings.

Online search strategies utilized in feigning attention deficit/hyperactivity disorder (ADHD) while performing a continuous performance test (CPT).

BACKGROUND: The availability of information regarding neuropsychological tests threatens their confidentiality. This concern may be particularly relevant to Attention-Deficit/Hyperactivity Disorder (ADHD) considering its widespread online coverage. The present study explored simulators' online search strategies. METHOD: Simulators (n = 39) searched for information before undergoing an evaluation which included performing a continuous performance test (CPT). Their search strategies were analyzed, and their performance was compared to that of ADHD patients (n = 36) and healthy controls (n = 38). RESULTS: Most simulators reached high-risk websites that provided written and video-based information regarding the test. Sixty percent, comprised mostly of 3rd-year students, reached Google Scholar. These students were also easier to detect as simulators. Common strategies included performing the CPT in accordance with typical ADHD symptoms and avoiding the endorsement of both unusual and stereotypical symptoms. CONCLUSION: Simulators can access online information that contains key test data. Higher education may increase the ability to reach academic research while decreasing the ability to convincingly feign impairment. While additional research is needed to examine coaching effects on neuropsychological testing, the risk to test security that many websites pose should be acknowledged and steps, including ones taken by test publishers, should be undertaken to minimize it.

Validating Embedded Validity Indicators of Feigned ADHD-Associated Cognitive Impairment Using the MOXO-d-CPT.

BACKGROUND: The current study aimed to validate the utility of previously established validity indicators derived from MOXO-d-CPT's continuous performance test. METHOD: Healthy simulators feigned impairment after searching online for relevant information, an ecologically valid coaching condition (n = 39). They were compared to ADHD patients (n = 36) and healthy controls (n = 38). RESULTS: Simulators performed significantly worse than ADHD patients in all MOXO-d-CPT indices, as well as a scale that integrates their contributions (feigned ADHD scale). Three indices (attention, hyperactivity, and impulsivity) and the latter scale exhibited adequate discriminative capacity. Higher education was associated with an exaggerated impairment among simulators, easing their detection. CONCLUSION: Similarity between the current study and a previous study which examned the utlity of the MOXO-d-CPT validity indicators, increases our confidence in the efficacy of the latters embedded validity indicators. Though the findings provide initial validation of these validity indicators, generalizing beyond highly functioning participants necessitates further research.

COVID-19: Impact of Diagnosis Threat and Suggestibility on Subjective Cognitive Complaints / COVID-19: impacto de la amenaza de diagnóstico y la sugestibilidad en las quejas cognitivas subjetivas

ResumenAntecedentes/Objetivo: Pacientes con COVID-19 recuperados informan síntomas neuro-lógicos persistentes (e.g., dolor de cabeza y fatiga) que se vieron afectados por procesos psicológicos en otros trastornos (e.g., Síndrome postconmoción cerebral después de una lesión cerebral traumática leve). Se evaluó el impacto de la amenaza del diagnóstico (i.e., información sobre el impacto neurológico a largo plazo del COVID-19) y la sugestión sobre los síntomas respaldados, tanto de pacientes recuperados como de controles sanos. Método: Pacientes recuperados (n = 90) y controles sanos (n = 210) informaron sobre su funcionamiento cognitivo después de haber sido asignados al azar a: (a) condición que exploró los síntomas neurológicos a largo plazo entre los sobrevivientes de COVID-19; (b) condición de control que proporciona información general sobre la enfermedad. Resulta­dos: Pacientes recuperados, pero no los controles sanos, aprobaron más síntomas en la condición experimental que en la condición control. La sugestión se asoció con una ma-yor aprobación de síntomas. Conclusiones: Los síntomas neurológicos posteriores al CO-VID-19 pueden verse afectados, al menos parcialmente, por factores no neurológicos como la amenaza del diagnóstico. La información sobre los efectos a largo plazo de CO-VID-19 puede sesgar los síntomas informados en individuos altamente sugestionables. Se necesitan más investigaciones para validar y desarrollar estos hallazgos iniciales.© 2021 Asociación Española de Psicología Conductual. Published by Elsevier España, S.L.U. This is an open access article under the CC BY−NC−ND license (http://creativecommons.org/licenses/by−nc−nd/4.0/)

AbstractBackground/Objective: A subset of recovered COVID-19 patients report persistent neuro-logical symptoms. These include non-specific symptoms (e.g., headaches and fatigue) which were found to be affected by psychological processes in other disorders (e.g., post-concussion syndrome after mild traumatic brain injury). The current study assessed the impact of diagnosis threat (i.e., information regarding the long-term neurological mpact of COVID-19) and suggestibility on endorsed symptoms of both recovered patients and healthy controls. Method: Recovered patients (n = 90) and healthy controls (n = 210) described their cognitive functioning after being randomly assigned to: (a) Experimental group: These participants read an article that explored long-term neurological symptoms among COVID-19 survivors. (b) Control group: These participants read an article providing general information regarding the disease. Results: Recovered patients, but not healthy controls, endorsed more symptoms in the experimental condition compared to the con-trol condition. Moreover, suggestibility was correlated with higher endorsement of symp-toms. Conclusions: Post COVID-19 neurological symptoms may, at least partially, be af-fected by non-neurological factors such as diagnosis threat. Information regarding long-term effects of COVID-19 may skew reported symptoms with highly suggestible indi-viduals particularly susceptible to these effects. Further research, however, is needed to validate and elaborate upon these initial findings.© 2021 Asociación Española de Psicología Conductual. Published by Elsevier España, S.L.U. This is an open access article under the CC BY−NC−ND license (http://creativecommons.org/licenses/by−nc−nd/4.0/).

Cogstate Brief Battery: Cognition and the feigning of cognitive impairment in chronic pain.

Chronic pain (CP) is often associated with cognitive impairment. The Cogstate Brief Battery (CBB), a computerized assessment battery, has been studied in several neuropsychiatric disorders but not in CP. Since feigning of cognitive impairment is common in CP, the current study aimed to assess the CBB's utility in differentiating CP patients (n = 64) from healthy participants (n = 33), as well as to assess the effect of simulating cognitive impairment by CP patients on performance in the battery. CP outpatients were randomly assigned to one of two groups: (a) Patients performing the CBB to the best of their ability. (b) Patients simulating cognitive impairment. Independent-samples t-tests indicated that three of four CBB tasks successfully differentiated CP patients from matched healthy controls. Additionally, an analysis of covariance (ANCOVA) indicated that CP patients who simulated cognitive impairment performed more poorly in all four CBB tasks, with the detection task having the strongest discrimination capacity. This is the first study to point toward the usefulness and sensitivity of the CBB for assessment of cognition and detection of feigned cognitive impairment in CP. Further studies are required to validate these preliminary findings and assess the CBB's utility in daily clinical practice.

Eye Tracking During a Continuous Performance Test: Utility for Assessing ADHD Patients.

OBJECTIVE: The use of continuous performance tests (CPTs) for assessing ADHD related cognitive impairment is ubiquitous. Novel psychophysiological measures may enhance the data that is derived from CPTs and thereby improve clinical decision-making regarding diagnosis and treatment. As part of the current study, we integrated an eye tracker with the MOXO-dCPT and assessed the utility of eye movement measures to differentiate ADHD patients and healthy controls. METHOD: Adult ADHD patients and gender/age-matched healthy controls performed the MOXO-dCPT while their eye movements were monitored (n = 33 per group). RESULTS: ADHD patients spent significantly more time gazing at irrelevant regions, both on the screen and outside of it, than healthy controls. The eye movement measures showed adequate ability to classify ADHD patients. Moreover, a scale that combined eye movement measures enhanced group prediction, compared to the sole use of conventional MOXO-dCPT indices. CONCLUSIONS: Integrating an eye tracker with CPTs is a feasible way of enhancing diagnostic precision and shows initial promise for clarifying the cognitive profile of ADHD patients. Pending replication, these findings point toward a promising path for the evolution of existing CPTs.

Identifying Feigned Cognitive Impairment: Investigating the Utility of Diffusion Model Analyses.

Forced-choice performance validity tests are routinely used for the detection of feigned cognitive impairment. The drift diffusion model deconstructs performance into distinct cognitive processes using accuracy and response time measures. It thereby offers a unique approach for gaining insight into examinees' speed-accuracy trade-offs and the cognitive processes that underlie their performance. The current study is the first to perform such analyses using a well-established forced-choice performance validity test. To achieve this aim, archival data of healthy participants, either simulating cognitive impairment in the Word Memory Test or performing it to the best of their ability, were analyzed using the EZ-diffusion model (N = 198). The groups differed in the three model parameters, with drift rate emerging as the best predictor of group membership. These findings provide initial evidence for the usefulness of the drift diffusion model in clarifying the cognitive processes underlying feigned cognitive impairment and encourage further research.

Response Time Measures as Supplementary Validity Indicators in Forced-Choice Recognition Memory Performance Validity Tests: A Systematic Review.

Performance validity tests (PVTs) based on the forced-choice recognition memory (FCRM) paradigm are commonly used for the detection of noncredible performance. Examinees' response times (RTs) are affected by cognitive processes associated with deception and can also be gathered without lengthening the duration of the assessment. Consequently, interest in the utility of these measures as supplementary validity indicators in FCRM-PVTs has grown over the years. The current systematic review summarizes both clinical and simulation (i.e., healthy participants simulating cognitive impairment) studies of RTs in FCRM-PVTs. The findings of 25 peer-reviewed articles (n = 26 empirical studies) indicate that noncredible performance in FCRM-PVTs is associated with longer RTs. Additionally, there are indications that noncredible performance is associated with larger variability in RTs. RT measures, however, have lower discrimination capacity than conventional accuracy measures. Their utility may therefore lie in reaching decisions regarding cases with border zone accuracy scores, as well as aiding in the detection of more sophisticated examinees who are aware of the use of accuracy-based validity indicators in FCRM-PVTs. More research, however, is required before these measures are incorporated in daily practice and clinical decision-making processes.

COVID-19: Impact of diagnosis threat and suggestibility on subjective cognitive complaints.

A subset of recovered COVID-19 patients report persistent neurological symptoms. These include non-specific symptoms (e.g., headaches and fatigue) which were found to be affected by psychological processes in other disorders (e.g., post-concussion syndrome, PCS, after mild traumatic brain injury). The current study assessed the impact of diagnosis threat (i.e., information regarding the long-term neurological impact of COVID-19) and suggestibility on endorsed symptoms of both recovered patients and healthy controls. Method: Recovered patients (n = 90) and healthy controls (n = 210) described their cognitive functioning after being randomly assigned to: (a) Experimental group: These participants read an article that explored long-term neurological symptoms among COVID-19 survivors. (b) Control group: These participants read an article providing general information regarding the disease. Results: Recovered patients, but not healthy controls, endorsed more symptoms in the experimental condition compared to the control condition. Moreover, suggestibility was correlated with endorsement of symptoms. Conclusions: Post COVID-19 neurological symptoms may, at least partially, be affected by non-neurological factors such as diagnosis threat. Information regarding long-term effects of COVID-19 may skew reported symptoms with highly suggestible individuals particularly susceptible to these effects. Further research, however, is needed to validate and elaborate upon these initial findings.

Pacientes con COVID-19 recuperados informan síntomas neurológicos persistentes (e.g., dolor de cabeza y fatiga) que se vieron afectados por procesos psicológicos en otros trastornos (e.g., Síndrome postconmoción cerebral después de una lesión cerebral traumática leve). Se evaluó el impacto de la amenaza del diagnóstico (i.e., información sobre el impacto neurológico a largo plazo del COVID-19) y la sugestión sobre los síntomas respaldados tanto de pacientes recuperados como de controles sanos. Método: Pacientes recuperados (n = 90) y controles sanos (n = 210) informaron sobre su funcionamiento cognitivo después de haber sido asignados al azar a: (a) condición que exploró los síntomas neurológicos a largo plazo entre los sobrevivientes de COVID-19; (b) condición de control que proporciona información general sobre la enfermedad. Resultados: Pacientes recuperados, pero no los controles sanos, aprobaron más síntomas en la condición experimental que en la control. La sugestión se asoció con una mayor aprobación de síntomas. Conclusiones: Los síntomas neurológicos posteriores al COVID-19 pueden verse afectados, al menos parcialmente, por factores no neurológicos como la amenaza del diagnóstico. La información sobre los efectos a largo plazo de COVID-19 puede sesgar los síntomas informados en individuos altamente sugestionables. Se necesitan más investigaciones para validar y desarrollar estos hallazgos iniciales.

Feigned ADHD Associated Cognitive Impairment: Utility of Integrating an Eye-tracker and the MOXO-dCPT.

OBJECTIVE: The current study assessed the utility of eye-movements measures, gathered while participants performed a commercially available Continuous Performance Test (CPT), to detect feigned ADHD-associated cognitive impairment. METHOD: Healthy simulators (n = 37), ADHD patients (n = 33), and healthy controls (n = 36) performed an eye-tracker integrated MOXO-dCPT and a stand-alone validity indicator. RESULTS: Simulators gazed significantly longer at regions that were irrelevant for successful MOXO-dCPT performance compared to ADHD patients and healthy controls. This eye-movement measure, however, had lower sensitivity than traditional MOXO-dCPT indices. DISCUSSION: Gaze direction measures, gathered while performing a CPT, show initial promise as validity indicators. Traditional CPT measures, however, are more sensitive and therefore offer a more promising path for the establishment of CPT-based validity indicators. The current study is an initial exploration of the issue and further evaluation of both theoretical and practical aspects is mandated.

The Multi-Level Pattern Memory Test (MPMT): Initial Validation of a Novel Performance Validity Test.

Performance validity tests (PVTs) are used for the detection of noncredible performance in neuropsychological assessments. The aim of the study was to assess the efficacy (i.e., discrimination capacity) of a novel PVT, the Multi-Level Pattern Memory Test (MPMT). It includes stages that allow profile analysis (i.e., detecting noncredible performance based on an analysis of participants' performance across stages) and minimizes the likelihood that it would be perceived as a PVT by examinees. In addition, it utilizes nonverbal stimuli and is therefore more likely to be cross-culturally valid. In Experiment 1, participants that were instructed to simulate cognitive impairment performed less accurately than honest controls in the MPMT (n = 67). Importantly, the MPMT has shown an adequate discrimination capacity, though somewhat lower than an established PVT (i.e., Test of Memory Malingering-TOMM). Experiment 2 (n = 77) validated the findings of the first experiment while also indicating a dissociation between the simulators' objective performance and their perceived cognitive load while performing the MPMT. The MPMT and the profile analysis based on its outcome measures show initial promise in detecting noncredible performance. It may, therefore, increase the range of available PVTs at the disposal of clinicians, though further validation in clinical settings is mandated. The fact that it is an open-source software will hopefully also encourage the development of research programs aimed at clarifying the cognitive processes involved in noncredible performance and the impact of PVT characteristics on clinical utility.

Executive functioning of older adults with bipolar disorder.

OBJECTIVES: Despite their impact on daily functioning, we have limited understanding of the executive functioning of older adults with bipolar disorder (OABD). Even less is known about the possible differences in the executive functioning of OABD and older adults with unipolar depression (OADEP). METHODS: After excluding acutely ill patients, the executive functioning of OABD was compared to that of OADEP and healthy controls (n = 22, n = 20, n = 22; respectively). Cognitive insight, a sub-domain of executive functioning, was operationalized as the discrepancy between the participants' self-reported cognitive functioning and appraisals that were made by their care partners. To complement the cognitive profiling, the groups were compared in information processing speed, verbal memory, and visual-spatial memory. RESULTS: OABD were impaired in several cognitive domains compared to healthy controls, most prominently in executive functioning and memory. OABD had poorer executive functioning and visual-spatial memory than OADEP. The findings also tentatively point toward intact cognitive insight among OABD, while OADEP seem to have a heightened level of awareness of their cognitive impairment. CONCLUSIONS: OABD have a unique profile of cognitive impairment compared to OADEP. It is characterized by a more severe cognitive impairment, accompanied by relatively intact cognitive insight. The findings may help clarify the cognitive profile of OABD and assist in the development of cognitive rehabilitation programs tailored to their needs. They should, however, be considered preliminary and await further research.

Detection of Feigned ADHD Using the MOXO-d-CPT.

Objective: The objective of this study was to assess the MOXO-d-CPT utility in detecting feigned ADHD and establish cutoffs with adequate specificity and sensitivity. Method: The study had two phases. First, using a prospective design, healthy adults who simulated ADHD were compared with healthy controls and ADHD patients who performed the tasks to the best of their ability (n = 47 per group). Participants performed the MOXO-d-CPT and an established performance validity test (PVT). Second, the MOXO-d-CPT classification accuracy, employed in Phase 1, was retrospectively compared with archival data of 47 ADHD patients and age-matched healthy controls. Results: Simulators performed significantly worse on all MOXO-d-CPT indices than healthy controls and ADHD patients. Three MOXO-d-CPT indices (attention, hyperactivity, impulsivity) and a scale combining these indices showed adequate discriminative capacity. Conclusion: The MOXO-d-CPT showed promise for the detection of feigned ADHD and, pending replication, can be employed for this aim in clinical practice and ADHD research.

Attention-Deficit/Hyperactivity Disorder (ADHD): Integrating the MOXO-dCPT with an Eye Tracker Enhances Diagnostic Precision.

Clinical decision-making may be enhanced when combining psychophysiological sensors with computerized neuropsychological tests. The current study explored the utility of integrating an eye tracker with a commercially available continuous performance test (CPT), the MOXO-dCPT. As part of the study, the performance of adult attention-deficit/hyperactivity disorder (ADHD) patients and healthy controls (n = 43, n = 42, respectively) was compared in the integrated system. More specifically, the MOXO-dCPT has four stages, which differ in their combinations of ecological visual and auditory dynamic distractors. By exploring the participants' performance in each of the stages, we were able to show that: (a) ADHD patients spend significantly more time gazing at irrelevant areas of interest (AOIs) compared to healthy controls; (b) visual distractors are particularly effective in impacting ADHD patients' eye movements, suggesting their enhanced utility in diagnostic procedures; (c) combining gaze direction data and conventional CPT indices enhances group prediction, compared to the sole use of conventional indices. Overall, the findings indicate the utility of eye tracker-integrated CPTs and their enhanced diagnostic precision. They also suggest that the use of attention-grabbing visual distractors may be a promising path for the evolution of existing CPTs by shortening their duration and enhancing diagnostic precision.

Open-Label placebo for the treatment of unipolar depression: Results from a randomized controlled trial.

BACKGROUND: The response to placebo is robust in studies of various antidepressant treatments. The strong placebo response, combined with the absence of side-effects, has prompted suggestions to use the ethically sound open-label placebo (OLP) as a treatment for depression. The aim of the present study was to assess the efficacy of OLP as an adjunct to treatment as usual (TAU) in the setting of a randomized controlled trial for the treatment of unipolar depression. METHODS: Thirty-eight patients (age: 50 ± 17.1; 73.7% females) were randomized to either eight-week OLP treatment (n = 18) or four weeks of TAU followed by four weeks of OLP (n = 20). Clinical and socio-demographic measures were assessed at baseline, after four weeks, and at the end of the trial. Response to treatment was determined using the QIDS SR-16. RESULTS: There was an overall decrease in depression levels over time, F(2,35) = 3.98, p = .028. A significant group x time interaction was found only among non-geriatric patients (<65years) with an early onset of depression (<50years), F(2,22) = 3.89, p = .036. Post-hoc tests indicated a significant decrease during the first four weeks, but only in the OLP group, t(11) = 2.29, p = .043. LIMITATIONS: Small sample size and the use of a self-report questionnaire to assess depressive symptoms. CONCLUSIONS: Our findings support the possibility that OLP is an effective treatment for the relatively young population of depressed patients. Additional studies are warranted to explore the use of OLP in clinical practice.